Global Biosimilars Market By Product Type (Monoclonal Antibodies, Recombinant Hormones, Anti-inflammatory Agents, and Other Product Types), Applications (Blood Disorders, Growth Hormonal Deficiency), By Region And Key Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends And Forecast 2023-2032
- Published date: Aug 2024
- Report ID: 96405
- Number of Pages: 302
- Format:
-
keyboard_arrow_up
-
-
- Novartis AG Company Profile
- Amgen Inc.
- Pfizer Inc Company Profile
- Viatris Inc.
- Eli Lilly
- Synthon Pharmaceuticals Inc.
- Teva Pharmaceutical Industries Ltd. Company Profile
- LG Life Sciences
- Celltrion
- Biocon Biologics Ltd.
- Coherus Biosciences, Inc.
- Bio-Thera Solutions
- Intas Pharmaceuticals Ltd.
- F. Hoffmann-La Roche Ltd.
- Samsung Bioepis Co.
- Hospira
- Merck Serono
- Biogen Idec Inc.
- Genentech
- settingsSettings
Our Clients
- 96405
- Aug 2024
Trusted by more than 17382 organizations globally
✖
Request a Sample Report
We'll get back to you as quickly as possible
|
Single User
$6,000
$3,999
USD / per unit
save 24%
|
Multi User
$8,000
$5,999
USD / per unit
save 28%
|
Corporate User
$10,000
$6,999
USD / per unit
save 32%
|
|
|---|---|---|---|
| e-Access | |||
| Report Library Access | |||
| Data Set (Excel) | |||
| Company Profile Library Access | |||
| Interactive Dashboard | |||
| Free Custumization | No | up to 10 hrs work | up to 30 hrs work |
| Accessibility | 1 User | 2-5 User | Unlimited |
| Analyst Support | up to 20 hrs | up to 40 hrs | up to 50 hrs |
| Benefit | Up to 20% off on next purchase | Up to 25% off on next purchase | Up to 30% off on next purchase |
| Buy Now ($ 3,999) | Buy Now ($ 5,999) | Buy Now ($ 6,999) |
